• No results found

Screening compounds and inhibitors

VIRTUAL SCREENING OF HETEROCYCLIC COMPOUNDS AGAINST ANGIOTENSIN CONVERTING ENZYME FOR POTENTIAL ANTIHYPERTENSIVE INHIBITORS

VIRTUAL SCREENING OF HETEROCYCLIC COMPOUNDS AGAINST ANGIOTENSIN CONVERTING ENZYME FOR POTENTIAL ANTIHYPERTENSIVE INHIBITORS

... ACE inhibitors is in progress that can be effective in the treatment of ...ACE inhibitors might give envisage the required chemical entities for the better ACE inhibition ...ACE inhibitors is used to ...

6

Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds

Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds

... novel inhibitors, we computationally screened a compound library of over 606 million compounds for binding at the recently solved crystal structure of the main protease (M pro ) of ...A screening of ...

17

Screening of ferulic acid related compounds as inhibitors of xanthine oxidase and cyclooxygenase-2 with anti-inflammatory activity

Screening of ferulic acid related compounds as inhibitors of xanthine oxidase and cyclooxygenase-2 with anti-inflammatory activity

... a major role in the uric acid production as XO is responsible for catalyzing the oxidation of hypoxanthine to form xanthine and finally to uric acid. Thus, this enzyme coordinates the reaction and produces uric acid from ...

6

Structure based virtual screening for identification of novel inhibitors against bace1 from selective medicinal plant compounds

Structure based virtual screening for identification of novel inhibitors against bace1 from selective medicinal plant compounds

... BACE1 inhibitors is the best treatment for ...616 compounds form 9 selective plant compounds using structure based virtual ...and compounds download from TCM ...

5

Repositioning therapeutics for COVID 19: virtual screening of the potent synthetic and natural compounds as SARS CoV 2 3CLpro inhibitors

Repositioning therapeutics for COVID 19: virtual screening of the potent synthetic and natural compounds as SARS CoV 2 3CLpro inhibitors

... potential inhibitors for treating COVID-19 using molecular docking based virtual screening ...synthetic compounds with various pharmacological usage such as antiviral, anti-inflammatory, anti-human ...

21

Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption

Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption

... kinase inhibitors in acidification of the resorp- tion lacunae and bone resorption by human ...the compounds. Furthermore, the specificity of the inhibitors is often not very high, and this is ...

11

Screening of new compounds for the management of erectile dysfunction

Screening of new compounds for the management of erectile dysfunction

... arteries. Inhibitors of phosphodiesterase type 5 (PDE5) enzyme like in sildenafi l, vardenafi l, tadalafi l ...new compounds for the management of erectile ...chemical compounds for increasing ...

5

Development of a Screening Assay for Type III Secretion System Inhibitors and High Throughput Screening Campaign of Inhibitors of PRP of Staphylococcus aureus

Development of a Screening Assay for Type III Secretion System Inhibitors and High Throughput Screening Campaign of Inhibitors of PRP of Staphylococcus aureus

... rapid screening, lab member Adam Johnson miniaturized the assay to 5 ...initial screening in this smaller volume, the signal observed decreased significantly and could not be quantified ...any ...

377

Gene expression based screening for inhibitors of PDGFR signaling

Gene expression based screening for inhibitors of PDGFR signaling

... throughput screening of small-molecule libraries is a well-established and highly productive tool for the identifica- tion of chemical compounds targeting a specific protein func- tion of ...high-throughput ...

14

Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities

Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities

... compounds were further tested towards their potential to inhibit Itch-mediated substrate ubiquitination, and only one compound was shown to inhibit Itch autoubiquitination and p73 ubiquitination. Further analysis ...

26

IN SILICO SCREENING FOR ALPHA GLUCOSIDASE INHIBITORS OF CHROMONE DERIVATIVES

IN SILICO SCREENING FOR ALPHA GLUCOSIDASE INHIBITORS OF CHROMONE DERIVATIVES

... alpha glucosidase available through the RCSB Protein Data Bank. The compounds were scored based on the minimized ligand protein complexes. New ligands were docked into the empty binding site of alpha glucosidase ...

7

In silico screening strategies for novel inhibitors of parasitic diseases

In silico screening strategies for novel inhibitors of parasitic diseases

... specialized screening tool to identify promising compounds based on their comple- mentarity to a specific binding ...virtual screening (SBVS), has made a remark- able impact on the discovery of new ...

10

Screening of selective histone deacetylase inhibitors by proteochemometric modeling

Screening of selective histone deacetylase inhibitors by proteochemometric modeling

... More recently, proteochemometric (PCM) modeling has been widely used to study the cross-interactions between a series of compounds and a series of proteins. In this area Maris Lapinsh et.al studied melanocortin ...

10

Identification of mutant p53 inhibitors by high-content screening

Identification of mutant p53 inhibitors by high-content screening

... The TP53 gene is the most commonly altered gene in human cancer. The majority of p53 mutations are missense and result in the accumulation of dysfunctional p53 protein in cancer cells. These mutant proteins frequently ...

99

Yeast-based assays for screening 11β-HSD1 inhibitors

Yeast-based assays for screening 11β-HSD1 inhibitors

... yeast-based screening systems described here rep- resent a valid alternative to currently available assays for screening of 11β-HSD1 inhibitors that are mainly based on the use of liver microsomes as ...

13

Virtual Screening for Novel HIV-Reverse Transcriptase Inhibitors

Virtual Screening for Novel HIV-Reverse Transcriptase Inhibitors

... HIV–1 (human immunodeficiency virus type–1) is the disease causing agent for AIDS. It is pathogenic retrovirus which joined in a long polypeptide chain when viral RNA is translated into a polypeptide sequence. It ...

5

Identification of novel serotonin transporter compounds by virtual screening.

Identification of novel serotonin transporter compounds by virtual screening.

... competitive inhibitors (inhibitors occupying the S2 site) 17−19 stabilizes the transporter in the outward-occluded conforma- ...competitive inhibitors and stabilize the transporters in an ...

12

Screening of Bioactive Compounds against Nonreceptor Fyn Kinase: Virtual Screening and Network Approach

Screening of Bioactive Compounds against Nonreceptor Fyn Kinase: Virtual Screening and Network Approach

... virtual screening of open and closed states of Fyn with seventy phytochemicals used in cancer treatment was carried ...the screening process by forming a data set containing seven potential ...efficient ...

8

Molecular Docking Studies; Dietary Compounds As HIV 1 Protease Inhibitors

Molecular Docking Studies; Dietary Compounds As HIV 1 Protease Inhibitors

... VIRTUAL SCREENING In rational drug design, protein structural data is used to predict the type of ligands that will interact with a given ...lead compounds is based on the high throughput ...Virtual ...

16

Vanadium Compounds as PTP Inhibitors

Vanadium Compounds as PTP Inhibitors

... oxidovanadium compounds into nanoparticles or nanocomposites that can be passively or actively targeted to ...vanadium compounds could be packaged into nanocarriers for delivery to tumour ...

19

Show all 10000 documents...

Related subjects